Author: Business Wire

Gemini Therapeutics Announces FDA Fast Track Designation Granted for GEM103 for the Treatment of Dry Age-Related Macular Degeneration (AMD) in Patients With Complement Factor H (CFH) Loss of Function Gene Variants

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Gemini Therapeutics, a clinical stage precision medicine company developing innovative treatments for genetically defined age-related macular degeneration (AMD), today announced that GEM103, the Company’s investigatio…

Global Laser-Assisted In-Situ Keratomileusis (LASIK) Surgery Markets, 2020-2024 – Increasing Medical Tourism for LASIK Surgery Driving Market Growth – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global Laser-Assisted In-Situ Keratomileusis (LASIK) Surgery Market 2020-2024” report has been added to ResearchAndMarkets.com’s offering. The laser-assisted in-situ keratomileusis (LASIK) surgery market is poised to grow …